The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Size Of The COVID-19 Current Therapy Market Progress Through 2030?
The covid-19 current therapy market size has experienced a steep decline in recent years. It is forecast to decrease from $2.35 billion in 2025 to $1.57 billion in 2026, at a compound annual growth rate (CAGR) of -33.2%. The reduction observed historically can be attributed to the sudden emergence of covid-19, elevated hospitalization rates, limited initial treatment options, diminishing government and healthcare initiatives, and fewer emergency drug approvals.
The market size for covid-19 current therapy is anticipated to experience a substantial decrease over the coming years. Its value is expected to fall to $0.31 billion in 2030, at a compound annual growth rate (CAGR) of -33.2%. This projected reduction during the forecast period is primarily due to a decline in telemedicine adoption for covid-19 management and a more limited expansion of home care services. Significant trends identified for the forecast period include an increasing embrace of antiviral and monoclonal antibody treatments, greater utilization of corticosteroids for critical covid-19 infections, an expansion of home care and remote patient monitoring options for covid-19, a proliferation of supplement and immune support therapies, and the incorporation of combination and experimental therapies into treatment strategies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3247&type=smp
Which Growth Drivers Are Expected To Support The COVID-19 Current Therapy Market Forward?
The expansion of healthcare infrastructure is projected to drive the growth of the COVID-19 current therapy market moving forward. The healthcare industry consolidates sectors of the economic system that deliver products and services aimed at curing, preventing, rehabilitating, and offering palliative care to patients. Healthcare infrastructure plays a vital role in the effective deployment of COVID-19 therapies, ensuring prompt patient care, supporting research and clinical trials, and providing essential resources for optimal treatment. For instance, in May 2023, the American Health Care Association, a US-based nonprofit organization, reported an increase in hospitals in the US to 6,129 from 6,093 in 2022. Furthermore, in May 2023, a report from the Office for National Statistics, a UK-based government department, showed that healthcare spending in the UK significantly increased by 9.4% in nominal terms and 9.7% in real terms. Thus, the growing healthcare industry is fueling the expansion of the COVID-19 current therapy market.
What Segment Categories Are Evaluated In The COVID-19 Current Therapy Market Study?
The covid-19 current therapy market covered in this report is segmented –
1) By Drug Type: Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs
2) By Route Of Administration: Oral, Intravenous
3) By End-User: Hospitals, Clinics, Home Care, Others
Subsegments:
1) By Antiviral: Remdesivir, Oseltamivir, Favipiravir, Nirmatrelvir Or ritonavir (Paxlovid)
2) By Monoclonal Antibodies: Bamlanivimab, Casirivimab Or Imdevimab (REGEN-COV), Sotrovimab, Etesevimab
3) By Corticosteroid: Dexamethasone, Hydrocortisone, Prednisone
4) By Supplements: Vitamin D, Vitamin C, Zinc, Quercetin
5) By Antimalarial: Hydroxychloroquine, Chloroquine
6) By Interferons and Interleukin Inhibitors: Interferon beta-1a, Interleukin-6 inhibitors
7) By Other Anti-Infective Drugs: Antibiotics, Antifungal Agents
What Trends Are Shaping The COVID-19 Current Therapy Market Structure?
Leading companies within the COVID-19 current therapy market are intensifying their efforts to introduce novel products, such as oral antiviral treatments for COVID-19, to secure a competitive advantage. Antiviral treatments are medications designed to prevent viruses from replicating and spreading throughout the body. For instance, in April 2024, Invivyd, a US-based firm specializing in antibody-based therapies for serious viral infectious diseases, provided an update regarding the introduction of PEMGARDA™. This occurred subsequent to receiving emergency use authorization (EUA) from The U.S. Food and Drug Administration (FDA). PEMGARDA rapidly became accessible for commercial distribution, with its aim being to prevent COVID-19 in individuals with moderate-to-severe immune compromise.
Which Organizations Are Involved In The COVID-19 Current Therapy Market?
Major companies operating in the covid-19 current therapy market are Gilead Sciences Inc., Ipca Laboratories Limited, Zydus Cadila, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, AbbVie, Glenmark Pharmaceuticals Limited, Eli Lilly and Company, Wallace Pharmaceuticals Inc., Canary Health Technologies, Thermo Fisher Scientific
Access The Complete COVID-19 Current Therapy Market Report:
https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report
Which Regional Market Leads The COVID-19 Current Therapy Market?
North America is the largest region in the COVID-19 current therapy market in 2025. Middle East is expected to be the fastest-growing region in the global COVID-19 current therapy market share during the forecast period. The regions covered in the covid-19 current therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access COVID-19 Current Therapy Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=3247&type=smp
Browse Through More Reports Similar to the Global COVID-19 Current Therapy Market 2026, By The Business Research Company
Hydroxychloroquines Market Report 2026
https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report
Covid 19 Detection Test Kits And Consumables Market Report 2026
Covid 19 Rapid Test Kits Market 2026
https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model